Hematopoietic Stem Cell Transplantation

Feb 18, 2017 by in ONCOLOGY Comments Off on Hematopoietic Stem Cell Transplantation

Evaluation   Growth Height, bone age, somatomedin C, IGFBP-3 TBI and/or cranial irradiation: refer to endocrinologist for GH provocative testing; growth hormone may be indicated Thyroid Physical assessment, free T4, T3,…

read more

Facilitating Assessment of Late Effects by Organ System

Feb 18, 2017 by in ONCOLOGY Comments Off on Facilitating Assessment of Late Effects by Organ System

Late effects Causative treatment Signs and symptoms Screening and diagnostic tests Management and intervention Chemotherapy Radiation Surgery Overt hypothyroidism (elevated TSH, decreased T4)  >20 Gy to the neck, cervical spine…

read more

The Ovary

Feb 18, 2017 by in ONCOLOGY Comments Off on The Ovary

Minimum ovarian dose (GY) Effect 0.6 None 1.5 No deleterious effect in most young women. Some risk of sterilization especially in women aged >40 2.5–5.0 Variable. Aged 15–40 years: about…

read more

Perineal Prostatectomy

Feb 18, 2017 by in ONCOLOGY Comments Off on Perineal Prostatectomy

Fig. 7.1 Depiction of anatomy in the midsagittal plane along with two approaches for RPP. BL bladder, P prostate, RH rhabdosphincter, RU rectourethralis; puboprostatic complex consists of puboprostatic ligaments (PPL—red);…

read more

Robotic Prostatectomy

Feb 18, 2017 by in ONCOLOGY Comments Off on Robotic Prostatectomy

Fig. 6.1 Port position The patient is then placed in extreme trendelenburg position. The robot is brought in and docked between the patient’s legs (Fig. 6.2). The assistant works from…

read more

Prostate Cryoablation

Feb 18, 2017 by in ONCOLOGY Comments Off on Prostate Cryoablation

Factor Comments Freeze rate Rapid freeze > Slow Freeze Cancer cells adapt to slow freeze Temperature monitor Strongly advises for monitor Nadir temperature Traditionally −40 °C was used Recommend −20 °C Thaw…

read more

Brachytherapy

Feb 18, 2017 by in ONCOLOGY Comments Off on Brachytherapy

Fig. 8.1 Cleveland Clinic institutional outcomes by NCCN risk category between 1996–2014. Part (a) is low-risk, part (b) intermediate-risk and part (c) high risk. The number at-risk at 5 and…

read more

Focal Ablation for Prostate Cancer

Feb 18, 2017 by in ONCOLOGY Comments Off on Focal Ablation for Prostate Cancer

Fig. 10.1 Perineal template with inserted cryoprobes to treat right side distal lesion Fig. 10.2 Inserted cryoprobe needles as seen on ultrasound image Fig. 10.3 Iceball—transverse view Fig. 10.4 Iceball—sagittal…

read more
Get Clinical Tree app for offline access